What is ESWL

ESWL: The Latest Advancement in the Treatment of Kidney Stones

Extracorporeal shock wave lithotripsy (ESWL) has, for the first time, provided a completely noninvasive technique for the managment of kidney stone disease. The procedure has been in use worldwide for nearly 20 years and has revolutionized the management of kidney stone disease by "blasting" stones into smaller particles that are easier to pass through the urine.

Put an End to Post-ESWL Recurrences

Treatment advancements, such as ESWL, are successful at removing stones, but the technique cannot help prevent stone recurrence. Reason being, ESWL has no effect on underlying metabolic abnormalities and does not alter a patient's predisposition to recurrent stone formation. In addition, residual stone fragments remain in approximately 30% of the patients treated with ESWL, which can lead to clinically relevant recurrences of stone formation.

Preventative therapy with UROCIT^®-K (potassium citrate, wax matrix tablets) picks-up where ESWL leaves off. UROCIT^®-K actually helps to reduce stone-forming activity from residual stone fragments after ESWL, by correcting the abnormal metabolic environment.